Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M Carmen, Chillón"'
Autor:
María García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, Cristina Jiménez, M. Eugenia Sarasquete, M. Carmen Chillón, Alejandro Medina, Ana Balanzategui, Rebeca Maldonado, Alicia Antón, Marta Rodríguez, Oscar Blanco, Luis G. Díaz, Pilar Tamayo, Pedro Blanco, Carmen Esteban, Verónica González-Calle, Noemí Puig, Norma Gutiérrez, Alejandro Martín, Ramón García-Sanz, Marcos González, M. Dolores Caballero, Miguel Alcoceba
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/4f9fac68cb9b488ea6a092caa80ff97d
Autor:
María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Noemí Puig, Alicia Antón, Ana Balanzategui, Isabel Prieto-Conde, Cristina Jiménez, María E Sarasquete, M Carmen Chillón, María Laura Gutiérrez, Rocío Corral, José María Alonso, José Antonio Queizán, Julia Vidán, Emilia Pardal, María Jesús Peñarrubia, José M Bastida, Ramón García-Sanz, Luis Marín, Marcos González
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172978 (2017)
Molecular alterations leading progression of asymptomatic CLL-like high-count monoclonal B lymphocytosis (hiMBL) to chronic lymphocytic leukemia (CLL) remain poorly understood. Recently, genome-wide association studies have found 6p21.3, where the hu
Externí odkaz:
https://doaj.org/article/9fdbc267667d4ca8831c32bdcb447e95
Autor:
Marta Pratcorona, M. Carmen Chillón, María José Calasanz, Maite Gómez Casares, Eva Barragán, Beatriz Bellosillo, Rosa Ayala, Jorge Sierra, Ramón García Sanz
Publikováno v:
Revista Sangre. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f600139a34fafd7c6f4e77030afdf3b2
https://doi.org/10.24875/sangre.21000005
https://doi.org/10.24875/sangre.21000005
Autor:
Luis A. Corchete, Alejandro Medina, Miguel Alcoceba, Cristina Jiménez, M. Isabel Prieto-Conde, Rebeca Maldonado, M. Carmen Chillón, M. Eugenia Sarasquete, Norma C. Gutiérrez, Verónica González-Calle, María García-Álvarez, Noemi Puig, Ana Balanzategui, Ramón García-Sanz, Montserrat Hernández-Ruano, Marcos González-Díaz
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Acute myeloid leukemias (AMLs) are currently genomically characterized by karyotype, fluorescence in situ hybridization (FISH), real-time quantitative PCR, and DNA sequencing. Next-generation sequencing offers the promise of detecting all genomic les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfadaab44222537accdce897ac431d25
https://doi.org/10.1016/j.jmoldx.2019.08.002
https://doi.org/10.1016/j.jmoldx.2019.08.002
Autor:
Alejandro Medina, Luis G Díaz, M. Carmen Chillón, María García-Álvarez, Alejandro Martín, Pilar Tamayo, Sara Alonso-Álvarez, Isabel Prieto-Conde, Carmen López Esteban, Pedro Blanco, Cristina Jiménez, Oscar Blanco, M. Dolores Caballero, M. Eugenia Sarasquete, Marcos González, Ana Balanzategui, Alicia Antón, Ramón García-Sanz, Miguel Alcoceba, Rebeca Maldonado, Verónica González-Calle, Noemi Puig, Marta Rodríguez, Norma C. Gutiérrez
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 1, Pp 1-4 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
© The Author(s) 2021.
Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL, 20–30%) after diffuse large B-cell lymphoma (DLBCL). Despite the introduction of rituximab and the high response rate to first-line treatment,
Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL, 20–30%) after diffuse large B-cell lymphoma (DLBCL). Despite the introduction of rituximab and the high response rate to first-line treatment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64004bce4c5cc35f0bff1887a54406f6
https://doi.org/10.1038/s41408-020-00395-y
https://doi.org/10.1038/s41408-020-00395-y
Autor:
Alicia Antón, José Antonio Queizán, Verónica González-Calle, M. Eugenia Sarasquete, Marcos González, Alejandro Martín, Miguel Alcoceba, Alejandro Medina, Luis G Díaz, Ramón García-Sanz, Cristina Jimenez, Rebeca Cuello, Francisco Javier Díaz Gálvez, M. Carmen Chillón, Pilar Tamayo, Maria Vidal, Oscar Blanco, María García-Álvarez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The Hodgkin lymphoma (HL) genomic landscape is hardly known due to the scarcity of tumour cells in the tissue. Liquid biopsy employing circulating tumour DNA (ctDNA) can emerge as an alternative tool for non-invasive genotyping. By using a custom nex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353ec7d24da786bc866764e5b20bf5fa
http://hdl.handle.net/10261/261709
http://hdl.handle.net/10261/261709
Autor:
Verónica González-Calle, Marcos González, Marta Rodríguez, Alicia Antón, M. Dolores Caballero, M. Eugenia Sarasquete, Alejandro Medina, María García-Álvarez, M. Carmen Chillón, Ana Balanzategui, Sara Alonso-Álvarez, Noemi Puig, Cristina Jiménez, Isabel Prieto-Conde, Pilar Tamayo, Alejandro Martín, Rebeca Maldonado, Ramón García-Sanz, Oscar Blanco, Miguel Alcoceba
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood Cancer Journal
Blood Cancer Journal, Vol 9, Iss 7, Pp 1-10 (2019)
instname
Blood Cancer Journal
Blood Cancer Journal, Vol 9, Iss 7, Pp 1-10 (2019)
© The Author(s) 2019.
Follicular lymphoma (FL) is a heterogeneous disease whose pathogenesis remains partially unknown. Around 20% of FL patients experience early progression or treatment-refractory disease and 2–3% of patients per year exper
Follicular lymphoma (FL) is a heterogeneous disease whose pathogenesis remains partially unknown. Around 20% of FL patients experience early progression or treatment-refractory disease and 2–3% of patients per year exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd760459ff548f3d44a523c721f51bef
https://doi.org/10.1038/s41408-019-0213-9
https://doi.org/10.1038/s41408-019-0213-9
Autor:
Guillermo López-Ruano, Teresa L. Ramos, Angel Hernández-Hernández, Luis Ignacio Sánchez-Abarca, Silvia Preciado, Consuelo del Cañizo, Fermín Sánchez-Guijo, Marcos González, Natalia de las Heras, Sandra Muntión, Montserrat Hernández-Ruano, Belén Rosado, M. Carmen Chillón
Publikováno v:
Leukemia Research. 39:921-924
The expression of BCR-ABL in hematopoietic stem cells is a well-defined primary event in chronic myeloid leukemia (CML). Some reports have described the presence of BCR-ABL on endothelial cells from CML patients, suggesting the origin of the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a24dd85e4d497e96c8737e2d3e42dd
https://doi.org/10.1016/j.leukres.2015.05.014
https://doi.org/10.1016/j.leukres.2015.05.014
Autor:
M. Dolores Caballero, Luis Marín, Carlos Grande, Cristina Jimenez, M. Eugenia Sarasquete, Jesús F. San Miguel, Eva González-Barca, Alejandro Martín, Jose Luis Bello, M. Carmen Chillón, Ramón García-Sanz, Miguel Alcoceba, Carlos Panizo, Fatima De la Cruz, Marcos González, Carmen Albo, Rocío Corral, Elena Sebastián, Emilia Pardal, Ana Balanzategui, Noemi Puig
Publikováno v:
Blood. 122:1448-1454
Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease influenced by genetic and environmental factors. The role of the HLA system in tumor antigen presentation could be involved in susceptibility and disease control. We analyzed the phenotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f7d556ec239c9456f39ec7797d2074
https://doi.org/10.1182/blood-2013-02-483420
https://doi.org/10.1182/blood-2013-02-483420
Autor:
Emilia Pardal, Rocío Corral, Santiago Montes-Moreno, Miguel Alcoceba, Alejandro Martín, Ramón García-Sanz, Marcos González, Luis Marín, Noemi Puig, Ana Balanzategui, M. Eugenia Sarasquete, M. Dolores Caballero, Jesús F. San Miguel, Eva González-Barca, M. Carmen Chillón, Teresa Guzmán Flores, Elena Sebastián, David Gonzalez
Publikováno v:
The American Journal of Pathology. 181:1879-1888
The pathogenesis of diffuse large B-cell lymphoma (DLBCL) remains partially unknown. The analysis of the B-cell receptor of the malignant cells could contribute to a better understanding of the DLBCL biology. We studied the molecular features of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57a49fde012dd5b8254cb285261bdea8
https://doi.org/10.1016/j.ajpath.2012.07.028
https://doi.org/10.1016/j.ajpath.2012.07.028